Endometriosis: assessment on O-RADS and risk of malignant transformation
- PMID: 40137947
- DOI: 10.1007/s00261-025-04885-0
Endometriosis: assessment on O-RADS and risk of malignant transformation
Abstract
Endometriosis is a common disease, affecting approximately 10% of women of reproductive age. Several intersecting guidelines and consensus statements provide information on imaging diagnosis and surveillance strategies for endometriomas. SRU consensus panel recommendations provide information on initial detection of endometriosis on routine pelvic imaging. Revised American Society of Reproductive Medicine (rASRM) classification, the #ENZIAN classification, and the deep pelvic endometriosis index (dPEI) aim to assess the overall extent of disease and assist in presurgical planning. The Ovarian-Adnexal Reporting and Data System (O-RADS) aims to risk stratify lesions evaluated with US or MR based on their imaging morphology, from typical benign lesions to atypical presentations and malignant transformation. Emerging data shows increased risk of ovarian cancer in patients with endometriosis, especially following menopause and in those patients with long standing endometriosis. (Chen et al. in Front Oncol. 14:1329133, 2024;Streuli et al. in Climacteric. 20:138-143, 2017;Secosan et al. in Diagnostics (Basel). 10:134, 2020;Inceboz in Womens Health (Lond Engl). 11:711-715, 2015;Cassani et al. in Maturitas. 190, 2024;Gemmell et al. in Hum Reprod Update. 23:481-500, 2017;Giannella et al. in Cancers (Basel). 13:4026, 2021;) Current O-RADS guidelines mandate follow-up of endometriomas up to 2 years with further follow-up based on clinical factors. No consensus guidelines exist for imaging surveillance of patients with deep endometriosis from a malignancy standpoint. This review explores the imaging appearance of endometriomas, imaging features of malignant transformation, surveillance strategies and gaps in current literature, and attempts to better understand the risk of malignancy and to encourage further research for long-term imaging surveillance of endometriosis patients.
Keywords: Endometrioisis; MRI; Malignancy; O-RADS; Surveillance; Ultrasound.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: Priyanka Jha: O-RADS Steering Committee Member and Honorarium from World Class CME Angela Tong: Speaker honorarium from Siemens Healthineers × 1; Research support from Siemens Healthineer in the form of software and hardware.
Similar articles
-
Comparison of #Enzian classification and revised American Society for Reproductive Medicine stages for the description of disease extent in women with deep endometriosis.Hum Reprod. 2022 Sep 30;37(10):2359-2365. doi: 10.1093/humrep/deac187. Hum Reprod. 2022. PMID: 36066464
-
Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.Ultrasound Obstet Gynecol. 2023 Dec;62(6):891-903. doi: 10.1002/uog.27452. Ultrasound Obstet Gynecol. 2023. PMID: 37606287 Free PMC article.
-
Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.Ultrasound Obstet Gynecol. 2022 May;59(5):668-676. doi: 10.1002/uog.24777. Epub 2022 Apr 8. Ultrasound Obstet Gynecol. 2022. PMID: 34533862
-
Endometriosis and Infertility: Gynecological Examination Practical Guide.J Clin Med. 2025 Mar 12;14(6):1904. doi: 10.3390/jcm14061904. J Clin Med. 2025. PMID: 40142712 Free PMC article. Review.
-
Expert opinion on the use of transvaginal sonography for presurgical staging and classification of endometriosis.Arch Gynecol Obstet. 2023 Jan;307(1):5-19. doi: 10.1007/s00404-022-06766-z. Epub 2022 Nov 11. Arch Gynecol Obstet. 2023. PMID: 36367580 Free PMC article. Review.
References
-
- Chen B, Zhao L, Yang R, Xu T. New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment. Front Oncol. 2024;14: 1329133. https://doi.org/10.3389/fonc.2024.1329133 - DOI - PubMed - PMC
-
- Streuli I, Gaitzsch H, Wenger J-M, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric. 2017;20: 138–143. https://doi.org/10.1080/13697137.2017.1284781 - DOI - PubMed
-
- Secosan C, Balulescu L, Brasoveanu S, Balint O, Pirtea P, Dorin G, et al. Endometriosis in menopause-renewed attention on a controversial disease. Diagnostics (Basel). 2020;10: 134. https://doi.org/10.3390/diagnostics10030134 - DOI - PubMed - PMC
-
- Inceboz U. Endometriosis after menopause. Womens Health (Lond Engl). 2015;11: 711–715. https://doi.org/10.2217/whe.15.59 - DOI - PubMed
-
- Cassani C, Tedeschi S, Cucinella L, Morteo V, Camnasio CA, Tiranini L, et al. Menopause and endometriosis. Maturitas. 2024;190: 108129. https://doi.org/10.1016/j.maturitas.2024.108129 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources